{{!--
  Investigator's Brochure - Generic Product
  Section 10: References
  
  Template for ICH E6 (R2) compliant IB Section 10
  
  Data Sources:
  - literature (PubMed articles)
  - trials (ClinicalTrials.gov)
  - label (regulatory documents)
  
  Variables:
  - compound_name: string
  - literature: Literature[]
  - trials: Trial[]
  - label: Label
--}}

# 10. REFERENCES

## 10.1 Regulatory Documents

### 10.1.1 FDA Documents

{{#if label}}
1. **FDA Approved Labeling**
   - {{label.source}}
   - Application Number: {{#if label.application_number}}{{label.application_number}}{{else}}[Number]{{/if}}
   - Effective Date: {{#if label.effective_date}}{{date label.effective_date "YYYY-MM-DD"}}{{else}}[Date]{{/if}}
   - Available at: {{#if label.source_url}}{{label.source_url}}{{else}}[URL]{{/if}}
{{else}}
1. **FDA Approved Labeling**
   - [Product name] Prescribing Information
   - Application Number: [NDA/ANDA number]
   - Effective Date: [Date]
   - Available at: [URL]
{{/if}}

{{#if eq product_type "generic"}}
2. **FDA Orange Book**
   - Approved Drug Products with Therapeutic Equivalence Evaluations
   - {{#if rld_brand_name}}Reference Listed Drug: {{rld_brand_name}}{{else}}[RLD]{{/if}}
   - {{#if rld_application_number}}Application Number: {{rld_application_number}}{{else}}[NDA number]{{/if}}
   - {{#if te_code}}TE Code: {{te_code}}{{else}}[TE code]{{/if}}
   - Available at: https://www.accessdata.fda.gov/scripts/cder/ob/

3. **FDA Bioequivalence Guidance**
   - Guidance for Industry: Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs
   - U.S. Department of Health and Human Services, Food and Drug Administration
   - Center for Drug Evaluation and Research (CDER)
   - Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents
{{/if}}

### 10.1.2 ICH Guidelines

4. **ICH E6 (R2) Good Clinical Practice**
   - International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
   - ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1)
   - Step 4 version, dated November 9, 2016
   - Available at: https://www.ich.org/page/efficacy-guidelines

5. **ICH M3(R2) Nonclinical Safety Studies**
   - International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
   - ICH Harmonised Guideline: Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials
   - Available at: https://www.ich.org/page/multidisciplinary-guidelines

### 10.1.3 Other Regulatory Documents

6. **DailyMed**
   - National Library of Medicine
   - {{compound_name}} Product Information
   - Available at: https://dailymed.nlm.nih.gov/

7. **openFDA**
   - U.S. Food and Drug Administration
   - Open Data Portal
   - Available at: https://open.fda.gov/

---

## 10.2 Chemical and Pharmaceutical References

### 10.2.1 Chemical Databases

8. **PubChem**
   - National Center for Biotechnology Information
   - {{compound_name}} Compound Summary
   - {{#if compound.inchikey}}InChIKey: {{compound.inchikey}}{{else}}[InChIKey]{{/if}}
   - Available at: https://pubchem.ncbi.nlm.nih.gov/

9. **ChemSpider**
   - Royal Society of Chemistry
   - {{compound_name}} Chemical Structure
   - Available at: http://www.chemspider.com/

### 10.2.2 Pharmaceutical Compendia

10. **United States Pharmacopeia (USP)**
    - {{compound_name}} Monograph
    - USP-NF
    - Available at: https://www.usp.org/

---

## 10.3 Scientific Literature

### 10.3.1 Primary Research Articles

{{#if literature}}
{{#each literature}}
{{add @index 11}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/each}}
{{else}}
[List primary research articles cited in the IB]

Example format:
11. Author A, Author B, Author C. Article title. *Journal Name*. Year;Volume(Issue):Pages. doi: DOI. PMID: PMID.
{{/if}}

### 10.3.2 Review Articles

{{#if literature}}
{{#each literature}}
{{#if eq this.publication_type "Review"}}
{{add @index 100}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List review articles and meta-analyses]
{{/if}}

---

## 10.4 Clinical Trial References

### 10.4.1 ClinicalTrials.gov Registry

{{#if trials}}
**Registered Clinical Trials:**

{{#each trials}}
{{add @index 200}}. {{this.title}}
    - ClinicalTrials.gov Identifier: {{this.nct_id}}
    - Status: {{#if this.status}}{{capitalize this.status}}{{else}}[Status]{{/if}}
    - Phase: {{#if this.phase}}{{this.phase}}{{else}}[Phase]{{/if}}
    - Available at: https://clinicaltrials.gov/ct2/show/{{this.nct_id}}

{{/each}}
{{else}}
[List relevant clinical trials from ClinicalTrials.gov]

Example format:
200. Study Title
     - ClinicalTrials.gov Identifier: NCT########
     - Status: [Status]
     - Phase: [Phase]
     - Available at: https://clinicaltrials.gov/ct2/show/NCT########
{{/if}}

### 10.4.2 Published Clinical Trial Results

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "clinical trial"}}
{{add @index 300}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List published clinical trial results]
{{/if}}

---

## 10.5 Safety References

### 10.5.1 Adverse Event Databases

400. **FDA Adverse Event Reporting System (FAERS)**
     - U.S. Food and Drug Administration
     - {{compound_name}} Adverse Event Reports
     - Available at: https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers

401. **MedWatch**
     - FDA Safety Information and Adverse Event Reporting Program
     - Available at: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program

### 10.5.2 Safety Publications

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "safety"}}
{{add @index 500}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List safety-related publications]
{{/if}}

---

## 10.6 Pharmacology References

### 10.6.1 Pharmacokinetics

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "pharmacokinetics"}}
{{add @index 600}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List pharmacokinetic studies]
{{/if}}

### 10.6.2 Pharmacodynamics

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "pharmacodynamics"}}
{{add @index 700}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List pharmacodynamic studies]
{{/if}}

### 10.6.3 Drug Interactions

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "drug interaction"}}
{{add @index 800}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List drug interaction studies]
{{/if}}

---

## 10.7 Efficacy References

### 10.7.1 Pivotal Trials

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "efficacy"}}
{{add @index 900}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List pivotal efficacy trials]
{{/if}}

### 10.7.2 Supporting Studies

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "clinical study"}}
{{add @index 1000}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List supporting efficacy studies]
{{/if}}

---

## 10.8 Special Populations

### 10.8.1 Pediatric Studies

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "pediatric"}}
{{add @index 1100}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List pediatric studies]
{{/if}}

### 10.8.2 Geriatric Studies

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "geriatric"}}
{{add @index 1200}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List geriatric studies]
{{/if}}

---

## 10.9 Bioequivalence References

{{#if eq product_type "generic"}}
### 10.9.1 Bioequivalence Studies

{{#if literature}}
{{#each literature}}
{{#if includes this.keywords "bioequivalence"}}
{{add @index 1300}}. {{#each this.authors}}{{this}}{{#unless @last}}, {{/unless}}{{/each}}. {{this.title}}. *{{this.journal}}*{{#if this.publication_date}}. {{this.publication_date}}{{/if}}{{#if this.volume}};{{this.volume}}{{/if}}{{#if this.issue}}({{this.issue}}){{/if}}{{#if this.pages}}:{{this.pages}}{{/if}}. {{#if this.doi}}doi: {{this.doi}}{{/if}}{{#if this.pmid}} PMID: {{this.pmid}}{{/if}}.

{{/if}}
{{/each}}
{{else}}
[List bioequivalence studies for this generic product]
{{/if}}

### 10.9.2 FDA Bioequivalence Guidance

1400. **Guidance for Industry: Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs â€” General Considerations**
      - U.S. Department of Health and Human Services
      - Food and Drug Administration
      - Center for Drug Evaluation and Research (CDER)
      - March 2014
      - Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents
{{/if}}

---

## 10.10 Additional Resources

### 10.10.1 Online Databases

1500. **PubMed**
      - National Library of Medicine
      - National Center for Biotechnology Information
      - Available at: https://pubmed.ncbi.nlm.nih.gov/

1501. **ClinicalTrials.gov**
      - U.S. National Library of Medicine
      - Clinical Trials Registry
      - Available at: https://clinicaltrials.gov/

1502. **Drugs@FDA**
      - U.S. Food and Drug Administration
      - FDA-Approved Drugs Database
      - Available at: https://www.accessdata.fda.gov/scripts/cder/daf/

### 10.10.2 Professional Organizations

1503. **American Society of Clinical Pharmacology and Therapeutics (ASCPT)**
      - Available at: https://www.ascpt.org/

1504. **International Conference on Harmonisation (ICH)**
      - Available at: https://www.ich.org/

---

## 10.11 Reference Management

**Citation Style:** This Investigator's Brochure uses a numbered citation system consistent with ICH E6 (R2) guidelines.

**Reference Updates:** References are current as of {{date generated_at "YYYY-MM-DD"}}. New references will be added as additional information becomes available.

**Access:** All publicly available references include URLs for easy access. Proprietary or confidential references are available upon request to authorized personnel.

---

## 10.12 Data Sources Summary

This Investigator's Brochure compiled references from the following primary sources:

{{#if literature}}
- **PubMed Literature:** {{length literature}} articles
{{/if}}
{{#if trials}}
- **ClinicalTrials.gov:** {{length trials}} registered trials
{{/if}}
{{#if label}}
- **FDA Labeling:** {{label.source}}
{{/if}}
- **Regulatory Databases:** FDA Orange Book, DailyMed, openFDA
- **Chemical Databases:** PubChem, ChemSpider
- **Guidelines:** ICH E6 (R2), ICH M3(R2), FDA Guidance Documents

**Total References:** {{#if literature}}{{add (length literature) 20}}+{{else}}[Number]{{/if}}

---

*This section complies with ICH E6 (R2) guidelines for Investigator's Brochure content.*

*End of References Section*

*End of Investigator's Brochure Document*
